Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4 | 57 | 6 | 93 | N/A |
| Receivables | 2,590 | 2,592 | 2,550 | 2,550 | N/A |
| TOTAL | $2,594 | $2,650 | $2,556 | $2,643 | $N/A |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $2,594 | $2,650 | $2,556 | $2,643 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,042 | 4,020 | 0 | 4,229 | 0 |
| Accrued Expenses | 437 | 314 | 203 | 171 | N/A |
| TOTAL | $4,479 | $4,334 | $203 | $4,400 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 681 | 658 | 4,399 | 0 | 0 |
| TOTAL | $565 | $554 | $4,286 | $N/A | $N/A |
| Total Liabilities | $5,043 | $4,887 | $4,489 | $4,400 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,189 | 1,189 | 1,189 | N/A | N/A |
| Common Shares | 214 | 214 | 214 | 214 | N/A |
| Retained earnings | -16,572 | -16,353 | -16,039 | -15,777 | N/A |
| TOTAL | $-2,449 | $-2,238 | $-1,933 | $-1,757 | $N/A |
| Total Liabilities And Equity | $2,594 | $2,650 | $2,556 | $2,643 | $0 |